Don't want ads? Subscribe or login now.

Purdue Kicks Off Ch. 11 Confirmation With Plan Overview

By Vince Sullivan · November 12, 2025, 7:28 PM EST

Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Purdue Pharma L.P.

Case Number

7:19-bk-23649

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Vince

November 10, 2025
Sunnova Ch. 11 Wind-Down Approved Over Release Objection
November 07, 2025
Purdue Expects Smooth Confirmation Of New $7.5B Plan
November 03, 2025
Mediation Directive Stalls Office Building REIT Ch. 11 Fight
November 03, 2025
Cred Inc. Trust To Make $76M In Ch. 11 Crypto Payments
October 31, 2025
South African Airline's Deal With Boeing Approved In Ch. 15
October 31, 2025
Near's Ch. 11 Suit Says Auditor Failures Cost SPAC $400M
October 30, 2025
Linqto Keeps Ch. 11 Case Control Over Customer Opposition
October 29, 2025
Ga. Dorm Operator Gets Ch. 11 Disclosures OK'd
October 28, 2025
Dr. Phil Media Co. Bankruptcy Converted To Ch. 7
October 27, 2025
Dolphin Co. Can Sell Closed Park For $4.5M In Ch. 11